These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
5. [Biochemical aspects of human behaviour (author's transl)]. Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856 [No Abstract] [Full Text] [Related]
6. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732 [No Abstract] [Full Text] [Related]
7. [The significance of biogenic amines in cerebral infarction (author's transl)]. Jellinger K; Riederer P; Kothbauer P Wien Klin Wochenschr; 1979 May; 91(10):339-44. PubMed ID: 452604 [No Abstract] [Full Text] [Related]
8. The effect of serum from acute schizophrenic patients on rabbit brain amines. Ancill RJ; Harston SJ; Neubauer H; Redfern PH Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):255-60. PubMed ID: 5523275 [No Abstract] [Full Text] [Related]
10. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. Yang HY; Neff NH J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170 [No Abstract] [Full Text] [Related]
11. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain. Leonard BE Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855 [No Abstract] [Full Text] [Related]
13. Role of biogenic amines in certain pathological conditions. Subrahmanyam S Brain Res; 1975 Apr; 87(2-3):355-62. PubMed ID: 1125783 [No Abstract] [Full Text] [Related]
14. Neuropsychopharmacology of monoamines and their regulatory enzymes. Lipton MA Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941 [No Abstract] [Full Text] [Related]
15. [Behavioral disorders: possible correlation with biogenic cerebral amines]. Palermo Neto J; Carvalho FV Rev Paul Med; 1974 Mar; 83(3):137-44. PubMed ID: 4614362 [No Abstract] [Full Text] [Related]
16. [Monoamines (3): postmortem studies on the human brain in a suicide group]. Gottfries CG; Winblad B Lakartidningen; 1978 Feb; 75(8):663-5. PubMed ID: 634000 [No Abstract] [Full Text] [Related]
17. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain. Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467 [No Abstract] [Full Text] [Related]
20. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains. Chmielewska B Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]